Shorter Disease Duration Is Associated With Higher Rates of Response to Vedolizumab in Patients With Crohn’s Disease But Not Ulcerative Colitis
Titel:
Shorter Disease Duration Is Associated With Higher Rates of Response to Vedolizumab in Patients With Crohn’s Disease But Not Ulcerative Colitis
Auteur:
Faleck, David M. Winters, Adam Chablaney, Shreya Shashi, Preeti Meserve, Joseph Weiss, Aaron Aniwan, Satimai Koliani-Pace, Jenna L. Kochhar, Gursimran Boland, Brigid S. Singh, Siddharth Hirten, Robert Shmidt, Eugenia Kesar, Varun Lasch, Karen Luo, Michelle Bohm, Matthew Varma, Sashidhar Fischer, Monika Hudesman, David Chang, Shannon Lukin, Dana Sultan, Keith Swaminath, Arun Gupta, Nitin Siegel, Corey A. Shen, Bo Sandborn, William J. Kane, Sunanda Loftus Jr., Edward V. Sands, Bruce E. Colombel, Jean-Frederic Dulai, Parambir S. Ungaro, Ryan